Your browser doesn't support javascript.
loading
Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands.
Benali, Faysal; Stolze, Lotte J; Rozeman, Anouk D; Dinkelaar, Wouter; Coutinho, Jonathan M; Emmer, Bart J; Gons, Rob A R; Yo, Lonneke F S; van Tuijl, Julia H; Boukrab, Issam; van Dam-Nolen, Dianne H K; van den Wijngaard, Ido R; Lycklama À Nijeholt, Geert J; de Laat, Karlijn F; van Dijk, Lukas C; den Hertog, Heleen M; Flach, H Zwenneke; Wermer, Marieke J H; van Walderveen, Marianne A A; Brouwers, Paul J A M; Bulut, Tomas; Vermeer, Sarah E; Bernsen, Marie Louise E; Uyttenboogaart, Maarten; Bokkers, Reinoud P H; Boogaarts, Jeroen D; de Leeuw, Frank-Erik; van der Worp, H Bart; van der Schaaf, Irene C; Schonewille, Wouter J; Vos, Jan A; Remmers, Michel J M; Imani, Farshad; Dippel, Diederik W J; van Zwam, Wim H; Nederkoorn, Paul J; van Oostenbrugge, Robert J.
Afiliación
  • Benali F; Department of Neurology and Radiology & Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands. Faysal.benali@mumc.nl.
  • Stolze LJ; Department of Neurology and Radiology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Rozeman AD; Department of Neurology and Radiology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • Dinkelaar W; Department of Neurology and Radiology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • Coutinho JM; Department of Neurology and Radiology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Emmer BJ; Department of Neurology and Radiology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Gons RAR; Department of Neurology and Radiology, Catharina Hospital, Eindhoven, the Netherlands.
  • Yo LFS; Department of Neurology and Radiology, Catharina Hospital, Eindhoven, the Netherlands.
  • van Tuijl JH; Department of Neurology and Radiology, Elisabeth TweeSteden Hospital, Tilburg, the Netherlands.
  • Boukrab I; Department of Neurology and Radiology, Elisabeth TweeSteden Hospital, Tilburg, the Netherlands.
  • van Dam-Nolen DHK; Department of Neurology and Radiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van den Wijngaard IR; Department of Neurology and Radiology, Haaglanden Medical Center, The Hague, the Netherlands.
  • Lycklama À Nijeholt GJ; Department of Neurology and Radiology, Haaglanden Medical Center, The Hague, the Netherlands.
  • de Laat KF; Department of Neurology and Radiology, Haga Hospital, The Hague, the Netherlands.
  • van Dijk LC; Department of Neurology and Radiology, Haga Hospital, The Hague, the Netherlands.
  • den Hertog HM; Department of Neurology and Radiology, Isala Hospital, Zwolle, the Netherlands.
  • Flach HZ; Department of Neurology and Radiology, Isala Hospital, Zwolle, the Netherlands.
  • Wermer MJH; Department of Neurology and Radiology, Leiden University Medical Center, Leiden, the Netherlands.
  • van Walderveen MAA; Department of Neurology and Radiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Brouwers PJAM; Department of Neurology and Radiology, Medisch Spectrum Twente, Enschede, the Netherlands.
  • Bulut T; Department of Neurology and Radiology, Medisch Spectrum Twente, Enschede, the Netherlands.
  • Vermeer SE; Department of Neurology and Radiology, Rijnstate Hospital, Arnhem, the Netherlands.
  • Bernsen MLE; Department of Neurology and Radiology, Rijnstate Hospital, Arnhem, the Netherlands.
  • Uyttenboogaart M; Department of Neurology and Radiology, University Medical Center Groningen, Groningen, the Netherlands.
  • Bokkers RPH; Department of Neurology and Radiology, University Medical Center Groningen, Groningen, the Netherlands.
  • Boogaarts JD; Department of Neurosurgery and Neurology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.
  • de Leeuw FE; Department of Neurosurgery and Neurology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.
  • van der Worp HB; Department of Neurology and Neurosurgery and Radiology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • van der Schaaf IC; Department of Neurology and Neurosurgery and Radiology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Schonewille WJ; Department of Neurology and Radiology, Sint Antonius Hospital, Nieuwegein, the Netherlands.
  • Vos JA; Department of Neurology and Radiology, Sint Antonius Hospital, Nieuwegein, the Netherlands.
  • Remmers MJM; Department of Neurology and Radiology, Amphia Hospital, Breda, the Netherlands.
  • Imani F; Department of Neurology and Radiology, Amphia Hospital, Breda, the Netherlands.
  • Dippel DWJ; Department of Neurology and Radiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van Zwam WH; Department of Neurology and Radiology & Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Nederkoorn PJ; Department of Neurology and Radiology, Amsterdam UMC, Amsterdam, the Netherlands.
  • van Oostenbrugge RJ; Department of Neurology and Radiology & Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
BMC Neurol ; 22(1): 22, 2022 Jan 11.
Article en En | MEDLINE | ID: mdl-35016635
INTRODUCTION: We investigated the impact of the Corona Virus Disease 2019 (COVID-19) pandemic and the resulting lockdown on reperfusion treatments and door-to-treatment times during the first surge in Dutch comprehensive stroke centers. Furthermore, we studied the association between COVID-19-status and treatment times. METHODS: We included all patients receiving reperfusion treatment in 17 Dutch stroke centers from May 11th, 2017, until May 11th, 2020. We collected baseline characteristics, National Institutes of Health Stroke Scale (NIHSS) at admission, onset-to-door time (ODT), door-to-needle time (DNT), door-to-groin time (DGT) and COVID-19-status at admission. Parameters during the lockdown (March 15th, 2020 until May 11th, 2020) were compared with those in the same period in 2019, and between groups stratified by COVID-19-status. We used nationwide data and extrapolated our findings to the increasing trend of EVT numbers since May 2017. RESULTS: A decline of 14% was seen in reperfusion treatments during lockdown, with a decline in both IVT and EVT delivery. DGT increased by 12 min (50 to 62 min, p-value of < 0.001). Furthermore, median NIHSS-scores were higher in COVID-19 - suspected or positive patients (7 to 11, p-value of 0.004), door-to-treatment times did not differ significantly when stratified for COVID-19-status. CONCLUSIONS: During the first surge of the COVID-19 pandemic, a decline in acute reperfusion treatments and a delay in DGT was seen, which indicates a target for attention. It also appeared that COVID-19-positive or -suspected patients had more severe neurologic symptoms, whereas their EVT-workflow was not affected.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Accidente Cerebrovascular / Procedimientos Endovasculares / COVID-19 Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMC Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Accidente Cerebrovascular / Procedimientos Endovasculares / COVID-19 Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMC Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos